drugset
drugset / Trial / NCT04798638

A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers

NCT04798638 ↗

Phase 1 Completed 16 enrolled TYK Medicines, Inc
RandomizedCrossoverOpen-labelTreatment

Summary

To assess the pharmacokinetics of TY-9591 tablets and Osimertinib Mesylate tablets after a single fasting administration and the effect of food on the pharmacokinetics of TY-9591 tablets in healthy volunteers.

Timeline

Start
2021-04-30
Primary completion
2021-09-09
Completion
2021-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Osimertinib Small molecule 80 mg Oral
Subject TY-9591 Unknown 80 mg Oral

Indications

No indication recorded.